Advertisement
Research Article

Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting

  • Bin Wu,

    Affiliation: Clinical Outcomes and Economics Group, Department of Pharmacy, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Yifeng Miao,

    Affiliation: Neuroscience Center, Nanjing Medical University, Wuxi Second People's Hospital, Shanghai, China

    X
  • Yongrui Bai,

    Affiliation: Department of Radiotherapy, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Min Ye,

    Affiliation: Department of Oncology, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Yuejuan Xu,

    Affiliation: Department of Oncology, Medical School of South East University, The Second Hospital of Nanjing, Nanjing, China

    X
  • Huafeng Chen,

    Affiliation: Clinical Outcomes and Economics Group, Department of Pharmacy, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Jinfang Shen,

    Affiliation: Clinical Outcomes and Economics Group, Department of Pharmacy, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Yongming Qiu mail

    qiuzhoub@sina.com

    Affiliation: Department of Neurosurgery, School of Medicine, Shanghai Jiaotong University, Renji Hospital, Shanghai, China

    X
  • Published: April 12, 2012
  • DOI: 10.1371/journal.pone.0034588

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.